NCT07302230 2026-03-13
EMPOWER
University of Washington
Phase NA Recruiting
Clinical Trials
25 trialsNCT06528990 2026-03-05
Telehealth Intervention for Ostomy Self-Management
City of Hope Medical Center
Phase 2 Recruiting
NCT06040762 2026-03-02
A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
University of Washington
Phase NA Recruiting
NCT07206056 2026-03-02
TulmiSTAR-01
Novartis
Phase 1/2 Recruiting
NCT06855277 2026-02-24
AcTFirst
Novartis
Phase 3 Recruiting
NCT06563388 2026-02-04
ID-COMET
Roswell Park Cancer Institute
Phase 3 Recruiting
NCT07218718 2026-01-28
Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane Chemotherapy
City of Hope Medical Center
Phase NA Recruiting
NCT06296147 2026-01-16
Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy
University of Pittsburgh
Phase NA Recruiting
NCT03151629 2026-01-06
IRONMAN
Prostate Cancer Clinical Trials Consortium
Recruiting
NCT05519878 2025-12-24
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
City of Hope Medical Center
Phase NA Recruiting
NCT07087860 2025-12-09
RECIPE-B1
Mayo Clinic
Phase 2 Recruiting
NCT06046131 2025-11-17
KP-CARAIBES
Centre Hospitalier Universitaire de la Guadeloupe
Phase NA Recruiting
NCT05454488 2025-11-14
An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06014255 2025-10-29
HEAT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Recruiting
NCT05487846 2025-10-10
Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation
Thomas Jefferson University
Phase NA Recruiting
NCT05754658 2025-10-06
African Cancer Genome: GMD
Fox Chase Cancer Center
Recruiting
NCT06391099 2025-09-30
Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer
Ohio State University Comprehensive Cancer Center
Phase NA Recruiting
NCT07126860 2025-08-17
ZMoveMent-1
Ludwig-Maximilians - University of Munich
Phase NA Recruiting
NCT06401980 2025-08-14
Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Swiss Cancer Institute
Phase 2 Recruiting
NCT07053462 2025-07-08
CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
Phase 1/2 Recruiting
NCT06903312 2025-07-03
ITALIC-RCC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 4 Recruiting
NCT06496581 2024-12-20
Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)
UNICANCER
Phase 3 Recruiting
NCT06636682 2024-10-21
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
Cellvax Therapeutics Inc
Phase 2 Recruiting
NCT04694924 2024-05-22
Prosquare
Universitaire Ziekenhuizen KU Leuven
Recruiting
NCT05209243 2023-05-19
START-MET
Instituto de Investigación en OncologÃa Radioterápica - Fundación Española de OncologÃa Radioterápic
Phase NA Recruiting